95. FIS 2024 part 1: AMR & Bacteria

95. FIS 2024 part 1: AMR & Bacteria

Up next

137. Flucytosine

Flucytosine. A much maligned antifungal, consigned to adjuvant use in Cryptococcus... WELL THAT CHANGES... well not today because the resistance barrier is shockingly low, but at least in 20m time you'll know all you need to about 5-FC! Register for the BIA Spring Meeting 2026 he ...  Show more

136a. RIPL - Biosafety & Biosecurity

Lab containment levels 1-4Safety cabinets 1-3ACDP approved list of biological agents 2-4Counterterrorism act schedule 5 pathogensCat A and Cat B transport SAPO?!Confused? We're not surprised, but things will all become clear.... Once you listen to this masterclass from Dr Claire ...  Show more

Recommended Episodes

1. ORIGINS OF VIRUSES + my lab is a cult...
So Cultured Podcast

🦠Hey guys! Welcome to the FIRST episode of SERIES 4 of the So Cultured Podcast! This series we delve into the ORIGINS- looking at science through the lens of history! In This episode we are discussing the Origins of Viruses 🦠🔬


❓Where did viruses come from? What di ...

  Show more

Episode 114: Acute Promyelocytic Leukemia (REBOOT!)
The Fellow on Call: The Heme/Onc Podcast

By popular demand, our next series that we are excited to share with you is on MDS/AML! As we prepare for the release of the first episode next week, let’s throw it back to Episode 019 in our Heme/Onc Emergencies Series and talk about APL!

Episode contents:

- How ...

  Show more

Episode 1: Meet the Struggling Scientists
The Struggling Scientists

In this first episode, you meet the Struggling Scientists Hosts, Suzanne and Jayron! We introduce ourselves and this Science Podcast and talk about our goals!

We are Jayron and Suzanne, 2 PhD students in the world of Medical Biochemistry. Welcome to our new Podcast The S ...

  Show more

Episode 108: Colorectal Cancer Series, Pt. 10 - Metastatic Colorectal Cancer (Part 2)
The Fellow on Call: The Heme/Onc Podcast

This week, we round out our discussion on metastatic colorectal cancer, focusing on more targeted therapies for this disease. If you have not done so already, be sure to check out episode 107 for the first part of our metastatic colorectal cancer discussion.

Contents: </ ...

  Show more